United States
About Moderna, Inc.
Moderna, Inc. is a biotechnology company specializing in messenger RNA (mRNA) medicines, operating in the United States, Europe, and internationally.
Vaccines & Therapeutics
The company develops a diverse portfolio of vaccines and therapeutics, including:
- Respiratory Vaccines: Spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccines.
- Latent Vaccines: Cytomegalovirus, Epstein-Barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus (HIV) vaccines.
- Enteric Viruses: Norovirus vaccines.
- Public Health Vaccines: Zika, Nipah, and Mpox vaccines.
- Bacterial Diseases: Lyme disease vaccines.
- Oncology Therapeutics: Individualized neoantigen and checkpoint adaptive immune modulation therapy.
- Rare Disease Products: Propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, Crigler-Najjar syndrome type 1, and cystic fibrosis treatments.
Strategic Collaborations
Moderna has formed key partnerships with leading organizations, including:
- AstraZeneca
- Merck & Co., Inc.
- Vertex Pharmaceuticals Incorporated
- Generation Bio Co.
- immatics N.V.
- Life Edit Therapeutics
- Carisma Therapeutics, Inc.
- CytomX Therapeutics
- Defense Advanced Research Projects Agency (DARPA)
- Biomedical Advanced Research and Development Authority (BARDA)
- Institute for Life Changing Medicines
- The Bill & Melinda Gates Foundation
- OpenAI
Company Background
Founded in 2010 and headquartered in Cambridge, Massachusetts, Moderna was originally known as Moderna Therapeutics, Inc. before rebranding to Moderna, Inc. in August 2018.
